News
Microsoft PowerPoint provides live captioning and translated subtitling of a teacher’s lectures in many languages including English. These subtitles enable deaf or hard of hearing students and ...
security and ethical use” of the personal DNA data from about 15 million people in a $256 million deal to acquire assets of bankrupt 23andMe Holding Co. A biotechnology company based in ...
It is now testing the scaling of the process, which is a critical stage for biotech companies. "Ninety-five percent of biotechs fail when they leave a bench environment and go to a pilot plant or ...
MERCK has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times (FT) reported on Monday, citing three people familiar with the matter. MoonLake's ...
First, let’s take a look at the private biotech investments in May 2025, breaking them down by value, location, funding type, and therapeutic subsector. In May 2025, it was Pathos AI that secured the ...
The amount of funding going into biotechnology companies has fallen off over the last couple months, a trend the investment bank Jefferies pins on Trump administration policies aimed at gutting the ...
Before she became co-CEO of promising biotech firm Summit Therapeutics, Maky Zanganeh was a dentist, worked in robotic surgery, launched a blockbuster cancer drug and survived breast cancer.
BOSTON – McKinsey & Company’s consultants are increasingly drafting proposals and making PowerPoint slides using the firm’s generative artificial intelligence (AI) platform, which has ...
SOMERSET, N.J., June 03, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today new long-term results from the ...
Merck & Co., Inc. (NYSE:MRK) has explored a potential acquisition of Swiss biotech firm MoonLake Immunotherapeutics in a deal valued at over $3 billion, aiming to strengthen its drug pipeline.
Ned Lamont unveiled a proposed budget that includes welcome changes to Connecticut’s research and development tax credit with respect to biotech corporations. His proposed budget was formally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results